可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Carvajal K , MorenoSanchez R. Heart metabolic disturbances in cardiovascular diseases[J]. Arch Med Res, 2003,34(1):89-99.
[2] Rizxos I. Three years survival of patients with heart failure caused by dilated cardiomyopathy and Lcarnitine administration[J]. Am Heart J,2000, 139(2 pt 3):S120-S123
[3] 殷仁富,张治宇,时慧琦,等.左旋卡尼汀能有效提高稳定型心绞痛患者的运动耐量[J].心脏杂志,2006,18(4):442-444.
[4] Colonna P, Iliceto S. Myocardial infarction and left ventricular remodeling: result of the CEDIM trial. Carnitine Ecocardiografia Digitalizzata Infarto Miocardico [J]. Am Heart J, 2000, 139(2 pt 3) : S124-S130.
[5] 何勇,郑强荪,张录兴,等.左旋卡尼汀治疗慢性充血性心力衰竭的疗效观察[J]. 心脏杂志,2005,17(1):49-51.
[6] 肖立中,江志平,黄志,等.左旋卡尼汀对冠心病慢性心力衰竭患者心功能的影响[J].实用心脑肺血管病杂志,2004,12(1):1-3.
[7] 陈旭昌,何勇,郑强荪,等.左旋卡尼汀治疗缺血性心脏病心力衰竭临床观察 [J].心脏杂志,2004,16(1):94.
[8] wolff AA, Rotmensch HH, Stanley WC. Metabolic approaches to the treatment of ischemic heart disease:the clinicians'perspective[J]. Heart Fail Rev,2002,7(2): 187-203.